LLY vs MSTR · P/E 39, rev $65.18B vs rev $477.2M
Eli Lilly and Company (LLY) versus MicroStrategy Incorporated (MSTR) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
MicroStrategy Incorporated (MSTR) is a software - application company listed on US.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported MSTR revenue for 2025-12-31 was $477.2M. Net income was -$3.85B. Revenue was up 3.0% from 2024-12-31 to 2025-12-31. MSTR currently screens at market cap $52.71B.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. MSTR currently screens at market cap $52.71B.
Not investment advice. Open the LLY and MSTR stock pages for the full models.
Not investment advice.